Naval Aeromedical Research Unit, Dayton

Quick facts

Phase 3 pipeline

• Scopolamine Transdermal Patch [Transderm Scop] · Motion Sickness, Postoperative Nausea and Vomiting
  Scopolamine acts as a muscarinic acetylcholine receptor antagonist, blocking the action of acetylcholine at muscarinic receptors in the central and peripheral nervous system.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Naval Aeromedical Research Unit, Dayton portfolio CI brief
• Naval Aeromedical Research Unit, Dayton pipeline updates RSS